{"title":"Characterization and antibody preparation of the gene products of grouper iridovirus ORF120L","authors":"Chu-Fan Cheng , Hsiang-Chieh Chuang , Yu-Shen Lai","doi":"10.1016/j.virusres.2025.199625","DOIUrl":null,"url":null,"abstract":"<div><div>Grouper iridovirus (GIV) is regarded as a prominent viral pathogen of grouper, particularly during the larval and juvenile stages. The aim of this study was to comprehensively characterize the GIV-120L gene during viral infection. The results of sequence analysis suggest that GIV-120L is a 1,470 bp gene encoding a <em>Ranavirus</em>-specific viral protein. Recombinant GIV-120L protein was purified using a nickel-affinity column, and its molecular weight was found to be 59.1 kDa. To obtain antibodies against GIV, mice were immunized with recombinant GIV-120L protein, the spleen was harvested 8 weeks later, and hybridoma testing was performed using Sp2/0 myeloma cells. Polyclonal and monoclonal antibodies against GIV-120L were obtained. To characterize GIV-120L gene expression, grouper kidney (GK) cells were infected with GIV using cycloheximide (CHX) and cytosine arabinoside (AraC). GIV-120L transcripts and protein were found at 12–30 h post infection (hpi) and 18–30 hpi, respectively. In addition, inhibition with CHX and AraC confirmed that GIV-120L was a late gene. Immunofluorescence staining using the antibodies produced in the study confirmed that GIV-120L protein is expressed at viral assembly sites at 24 hpi. The findings of this study provide functional characterization of the GIV-120L viral gene, enhance understanding of GIV assembly, and offer insights for GIV diagnostic applications.</div></div>","PeriodicalId":23483,"journal":{"name":"Virus research","volume":"360 ","pages":"Article 199625"},"PeriodicalIF":2.7000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virus research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168170225001030","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Grouper iridovirus (GIV) is regarded as a prominent viral pathogen of grouper, particularly during the larval and juvenile stages. The aim of this study was to comprehensively characterize the GIV-120L gene during viral infection. The results of sequence analysis suggest that GIV-120L is a 1,470 bp gene encoding a Ranavirus-specific viral protein. Recombinant GIV-120L protein was purified using a nickel-affinity column, and its molecular weight was found to be 59.1 kDa. To obtain antibodies against GIV, mice were immunized with recombinant GIV-120L protein, the spleen was harvested 8 weeks later, and hybridoma testing was performed using Sp2/0 myeloma cells. Polyclonal and monoclonal antibodies against GIV-120L were obtained. To characterize GIV-120L gene expression, grouper kidney (GK) cells were infected with GIV using cycloheximide (CHX) and cytosine arabinoside (AraC). GIV-120L transcripts and protein were found at 12–30 h post infection (hpi) and 18–30 hpi, respectively. In addition, inhibition with CHX and AraC confirmed that GIV-120L was a late gene. Immunofluorescence staining using the antibodies produced in the study confirmed that GIV-120L protein is expressed at viral assembly sites at 24 hpi. The findings of this study provide functional characterization of the GIV-120L viral gene, enhance understanding of GIV assembly, and offer insights for GIV diagnostic applications.
期刊介绍:
Virus Research provides a means of fast publication for original papers on fundamental research in virology. Contributions on new developments concerning virus structure, replication, pathogenesis and evolution are encouraged. These include reports describing virus morphology, the function and antigenic analysis of virus structural components, virus genome structure and expression, analysis on virus replication processes, virus evolution in connection with antiviral interventions, effects of viruses on their host cells, particularly on the immune system, and the pathogenesis of virus infections, including oncogene activation and transduction.